drug · antibody
patient view →mezagitamab
Phase 3updated 2mo agoby $TAK TAKEDA PHARMACEUTICAL CO LTD🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 10 investigational indications.
targets
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that